Parkman Healthcare Partners LLC Ironwood Pharmaceuticals Inc Transaction History
Parkman Healthcare Partners LLC
- $708 Million
- Q3 2024
A detailed history of Parkman Healthcare Partners LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Parkman Healthcare Partners LLC holds 455,477 shares of IRWD stock, worth $1.69 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
455,477
Previous 876,268
48.02%
Holding current value
$1.69 Million
Previous $5.71 Million
67.23%
% of portfolio
0.26%
Previous 0.84%
Shares
5 transactions
Others Institutions Holding IRWD
# of Institutions
231Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$85.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$82 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$61 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$43.6 Million0.13% of portfolio
-
State Street Corp Boston, MA9.92MShares$36.9 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $570M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...